Cargando…
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508328/ https://www.ncbi.nlm.nih.gov/pubmed/36151090 http://dx.doi.org/10.1038/s41408-022-00733-2 |
| _version_ | 1784796992425164800 |
|---|---|
| author | Gill, Sarvarinder K. Unawane, Rashmi Wang, Shuqi Ahn, Jaeil Aleman, Adolfo Siegel, David S. Vesole, David H. Parmar, Harsh Phull, Pooja Biran, Noa |
| author_facet | Gill, Sarvarinder K. Unawane, Rashmi Wang, Shuqi Ahn, Jaeil Aleman, Adolfo Siegel, David S. Vesole, David H. Parmar, Harsh Phull, Pooja Biran, Noa |
| author_sort | Gill, Sarvarinder K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9508328 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95083282022-09-25 I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients Gill, Sarvarinder K. Unawane, Rashmi Wang, Shuqi Ahn, Jaeil Aleman, Adolfo Siegel, David S. Vesole, David H. Parmar, Harsh Phull, Pooja Biran, Noa Blood Cancer J Correspondence Nature Publishing Group UK 2022-09-23 /pmc/articles/PMC9508328/ /pubmed/36151090 http://dx.doi.org/10.1038/s41408-022-00733-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Gill, Sarvarinder K. Unawane, Rashmi Wang, Shuqi Ahn, Jaeil Aleman, Adolfo Siegel, David S. Vesole, David H. Parmar, Harsh Phull, Pooja Biran, Noa I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title | I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title_full | I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title_fullStr | I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title_full_unstemmed | I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title_short | I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| title_sort | i-open: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508328/ https://www.ncbi.nlm.nih.gov/pubmed/36151090 http://dx.doi.org/10.1038/s41408-022-00733-2 |
| work_keys_str_mv | AT gillsarvarinderk iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT unawanerashmi iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT wangshuqi iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT ahnjaeil iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT alemanadolfo iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT siegeldavids iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT vesoledavidh iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT parmarharsh iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT phullpooja iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients AT birannoa iopeninferioroutcomesofpentarefractorycomparedtopentaexposedmultiplemyelomapatients |